GPNV-001
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for GPNV-001, covering 2024-12-18 to 2024-12-18. Get the full timeline:
Most recent: Clinical Trial Update: Extension Safety and Immunogenicity Study of GPNV-001 [Phase 1, Phase 2]